Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:15 PM
Ignite Modification Date: 2025-12-24 @ 10:15 PM
NCT ID: NCT06532435
Eligibility Criteria: Inclusion Criteria: * Participants must be 2-6 years old * Healthy children of normal development, without gender restrictions, with a male to female ratio of more than 40%; * During the trial period, participants agree not to take any medications, supplements, or other nutritional products containing DHA and ARA; * Parents or legal guardians (at least one party) have signed an informed consent form, voluntarily participating in this study and complying with the study design; * Willing to not participate in other interventional nutritional studies during the trial period; * Capable of fully understanding the nature, purpose, benefits, and potential risks and side effects of this study. Exclusion Criteria: * Allergic to dairy products; * Severely intolerant to milk dairy products; * Unable to provide written informed consent; * During the screening period, or within the past two weeks, has used antibiotics; * Currently taking therapeutic medications; * The volunteer has any of the following medical histories or has been nutritionally diagnosed with any of the following diseases: significant gastrointestinal dysfunction, liver, kidney, endocrine, blood, respiratory, or cardiovascular diseases, which may affect the assessment of the trial's effects; * Suffering from any gastrointestinal dysfunction or gastrointestinal disease. For example, but not limited to: Irritable Bowel Syndrome (IBS), enteritis, ulcerative colitis, celiac disease, irritable bowel syndrome; * Has a history of hospitalization within the past 3 months; * According to the researcher's judgment, currently frequently using medications that may affect gastrointestinal function or the immune system.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 2 Years
Maximum Age: 6 Years
Study: NCT06532435
Study Brief:
Protocol Section: NCT06532435